Catch up on this week's highlights in retina.
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Belite Bio concludes phase 3 DRAGON study for Stargardt disease
PHOTON Trial Outcomes: Impact on DME Patient Care in Clinical Practice
Optain Health secures $26 million Series A funding
Implementing Higher Molar Dose in Your Clinical Practice
New company OpZira formed following Alcon’s acquisition of LumiThera
University of Houston researchers receive $3.6 million to examine retinal diseases